Tema: CM 02 - Estratégias de análise para doença residual mínima em leucemia linfóide B após imunoterapia / terapia alvo
Palestrante(s): Sindhu Cherian,
CM 02 – Estratégias de análise para doença residual mínima em leucemia linfóide B após imunoterapia / terapia alvo
CM 02 – Estratégias de análise para doença residual mínima em leucemia linfóide B após imunoterapia / terapia alvo
(Analysis Strategies for Minimal Residual Disease in Lymphoid B Leukemia after target therapy)
Coordenação: Nydia Bacal
Sindhu Cherian
Apoio: BECKMAN COULTER LIFE SCIENSES
Sindhu Cherian – 16/08/21 Dr. Cherian is an Associate Director of the Hematopathology Laboratory at the University of Washington. President of International Clinical Cytometry Society (2019-2021). Dr. Cherian’s research interests include expanding the role of flow cytometry in the clinical laboratory. She is also very interested in medical education. Hematology (Pathology), 2005, American Board of Pathology Clinical Pathology, 2004, American Board of Pathology.
e.vents_lab @ 2020
